Product
DPP-4i
1 clinical trial
1 indication
Indication
Type 2 Diabetes MellitusClinical trial
Effects of Gliflozins on Markers of Cardiovascular Risk in Type 2 Diabetes (GIOIA): a Multicenter Pragmatic Prospective Cohort StudyStatus: Completed, Estimated PCD: 2023-12-31